Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:05 AM UTC
| NCT Number | NCT05417594 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 695 participants |
| Active Locations | 11 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 19, 2026: Clinical trial NCT05417594 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05417594 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05417594 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.